DailyIQ
|
Last updatedUpdating…

TEM·Tempus AI Inc. Class A

$68.65
+2.48 (+3.75%)
After Hours
High
$70.79
Open
$66.58
Market Cap
9.80B
52W High
$104.32
Low
$63.61
P. Close
$68.65
P/E
-
52W Low
$40.77
Fwd P/E
-4521.71
DailyIQ Est.
$65.74
Inst. Ownership
-
Short Interest
24.43%
Technical Score (1D)
82
BUY
News Sentiment
44
BEARISH
BTIG’s latest upgrade of Tempus AI to a Buy and the lift of its price target to $80, announced 24.7 hours ago, signals renewed confidence in the company’s AI‑driven oncology platform and its recent strategic moves, including the multi‑billion dollar acquisition of Personalis. The rating reflects the firm’s belief that the added data and analytical capabilities will accelerate product development and market penetration, potentially boosting revenue streams over the next 1–10 trading days. This upgrade follows a 44.8‑hour‑old market rally triggered by a Merck‑Moderna cancer trial that validated the Personalis acquisition, confirming that the integrated diagnostics can effectively support novel therapeutics. The trial’s positive results reinforce the narrative that Tempus AI’s platform can deliver actionable insights in real‑time clinical settings, which may translate into higher adoption rates by oncology providers. Together, the upgrade and the trial validation suggest that the company’s valuation is now more aligned with its growth prospects, and traders should monitor upcoming earnings releases for evidence of revenue acceleration. Watch for any further clinical data releases from the Merck‑Moderna partnership, as additional positive outcomes could sustain the bullish momentum. Also keep an eye on integration milestones related to Personalis, particularly any progress in data harmonization and platform deployment, which will be critical for realizing the projected synergies. Finally, be alert for any regulatory updates that could affect the approval timeline for new AI‑enabled diagnostics, as delays could temper the short‑term upside.

EPS

EstBeatMiss
$-0.19$-0.16$-0.12$-0.09$-0.06Q3'25Q3'26
QtrEstActual+/−
Q3'26$-0.07 - -
Q3'25$-0.18$-0.11+37.3%

Revenue

EstBeatMiss
$322M$348M$374M$401M$427MQ3'25Q3'26
QtrEstActual+/−
Q3'26$415M - -
Q3'25 - $334M -
Full Earnings BreakdownEstimates, actuals, guidance, and historical context
→

Market Data

TEM Stock Snapshot

TEM is currently trading at $68.49, giving Tempus AI Inc. Class A a market cap of 9.80B. Today's range spans $63.61–$70.79, with shares opening at $66.58 and moving down $0.16 (0.2%) from the prior close. DailyIQ's technical score sits at 82/100 (BUY) with a news sentiment reading of 44/100.

Over the past year TEM has traded between $40.77 and $104.32 - the current price is +68.0% off the 52-week low and -34.3% from the high. 23 analysts cover the stock with a Hold consensus and a mean 12-month target of $63.36 (range $35.00–$100.00), implying downside of -7.5%.

At 9.80B in the broader market market cap, TEM isn't on every institutional screen - yet. The current setup (BUY, 82/100, neutral sentiment at 44/100, price $68.49 (in the middle of its 52-week range)) is the kind of data profile that changes that. When small-cap the broader market names show bullish technicals with aligned news sentiment, discovery buying and fundamental upgrades can accelerate the move beyond what the signal alone predicts. Range: $40.77–$104.32.

News sentiment (44/100, neutral) plays a larger role in small-cap price discovery than in mega-cap names, because the analyst coverage base is narrower and each incremental news item carries more weight in the information set. For TEM, 9.80B in the broader market market cap, technical score 82/100 (BUY), price $68.49 (in the middle of its 52-week range), a sustained improvement in the news backdrop could accelerate the bullish technical thesis toward the upper end of the $40.77–$104.32 range faster than fundamental models would suggest.